Moxolunic Eye Drop (Moxifloxacin 0.5% w/v) – Broad-Spectrum Antibacterial Eye Drop
Moxolunic Eye Drop contains Moxifloxacin 0.5% w/v, a fourth-generation fluoroquinolone antibiotic used to treat bacterial eye infections. It is highly effective against conjunctivitis (pink eye), corneal ulcers, and other ocular bacterial infections by inhibiting bacterial DNA gyrase, preventing their growth and spread.
This ophthalmic solution provides rapid relief from redness, swelling, and discomfort while ensuring broad-spectrum antibacterial protection. Moxolunic Eye Drop is WHO-GMP certified and suitable for pharma export, third-party manufacturing, and PCD pharma franchise opportunities.
Some individuals may experience mild irritation, burning, or a stinging sensation after applying the eye drops. Other possible side effects include redness, itching, dryness, excessive tearing, or temporary blurred vision. In rare cases, severe allergic reactions such as swelling, persistent pain, or worsening infection may occur, requiring immediate medical attention.
Moxolunic Eye Drop is used to treat bacterial eye infections, including conjunctivitis (pink eye), corneal ulcers, and other ocular bacterial conditions. It helps reduce symptoms like redness, swelling, irritation, and discharge caused by bacterial infections.
This medication is for external use only and should be used as directed by a healthcare professional. Avoid touching the dropper tip to any surface, including the eye, to prevent contamination. Contact lenses should be removed before application and reinserted at least 15 minutes after use. Completing the full course of treatment is crucial to prevent bacterial resistance and ensure effective recovery.
Moxolunic Eye Drop should be stored in a cool, dry place below 25°C, away from direct sunlight. It should not be frozen, and the bottle must be kept tightly closed to prevent contamination. The solution should be discarded one month after opening to maintain sterility. Keep it out of reach of children.